The PKU Book
Phenylketonuria and Other Hyperphenylalaninemias
| ISBN: | 9783032266897 |
| Συγγραφέας: | Nenad Blau |
| Συγγραφείς: | Jerry Vockley, Anita MacDonald, Francjan van Spronsen |
| Ημ/νία έκδοσης: | 09/2026 |
| Μορφή: | Hardcover |
| Αριθμός έκδοσης: | 1η έκδοση |
| Διαστάσεις: | 24x16 |
| Σελίδες: | 555 |
182,00€12% έκπτωση
161,00€ (συμπ. ΦΠΑ 6%)
23-28 ημέρες Υπό την προϋπόθεση ύπαρξης αποθέματος στον εκδότη
Phenylketonuria (PKU) is the most frequent inborn error of the amino acid metabolism (prevalence about 1:10,000 newborns). These autosomal-recessive inherited variants lead to deficiency in the PAH enzyme which hydroxylates phenylalanine to tyrosine, with the help of a cofactor (tetrahydrobiopterin; BH4), molecular oxygen, and non-heme iron. The metabolic picture is highly heterogenous as it depends on the degree of residual PAH activity and blood phenylalanine (Phe) concentrations. Untreated PKU generally results in global developmental delay or severe irreversible intellectual disability, as well as growth failure, hypopigmentation, motor deficits, ataxia, and seizures. The population of PKU-affected individuals is heterogeneous in terms of treatment history and diet compliance. Early diagnosis and treatment with a low-Phe diet has enabled an almost normal life for the majority of PKU subject. Pharmacological treatment with BH4 (sapropterin) and enzyme substitution therapy with Phe ammonia lyase (PAL) provide alternative treatment options for some PKU subjects. Several gene therapy trials are on the way.
The book includes the latest advancements in the pathophysiology of PKU, which is still not fully understood, as well as its management with new therapeutic options.
- The most current and comprehensive book on PKU
- Covers all aspects of the disease, from pathophysiology and diagnosis to treatment and the development of new drugs
- Edited and written by world-renowned experts in the field
Front Matter
Pages i-xxi
Download chapter PDF
History of PKU
Harvey L. Levy
Pages 1-9
Phenylalanine Hydroxylating System and Pathophysiology
Front Matter
Pages 11-11
Download chapter PDF
Phenylalanine Hydroxylase
Aurora Martinez, Mary Dayne S. Tai, Beat Thöny
Pages 13-24
Cofactor Tetrahydrobiopterin
Nenad Blau, Beat Thöny
Pages 25-36
DNAJC12 and Hsp70 Chaperones
Mary Dayne S. Tai, Aurora Martinez
Pages 37-48
The Regulatory Effect of Deubiquitinating Enzymes on the PAH Protein and Its Implications for Phenylketonuria
C. Bindu Ajaykumar, D. A. Ayush Gowda, Haribalan Perumalsamy, Aparna Jayachandran, Bharathi Suresh, Kye-Seong Kim et al.
Pages 49-62
Long Noncoding RNA (lncRNA) and Phenylalanine Hydroxylase
Nenad Blau, Francois Feillet
Pages 63-67
The Blood–Brain Barrier in Phenylketonuria
Francjan van Spronsen, Danique Draaisma-van Vliet, Charlotte Lubout
Pages 69-81
Toxicity of Phenylalanine
Guilhian Leipnitz, Carmen Regla Vargas
Pages 83-99
Animal Models for PKU and BH4 Deficiency
Beat Thöny, Aurora Martinez
Pages 101-112
Classification, Diagnosis and Genetics of PKU
Front Matter
Pages 113-113
Download chapter PDF
Tetrahydrobiopterin (BH4) Deficiencies
Thomas Opladen, Alberto Burlina, Vincenzo Leuzzi
Pages 115-135
DNAJC12
Yair Anikster, Ben Pode-Shakked, Rachel Rock
Pages 137-145
Diagnosis of Hyperphenylalaninemias
Allissia Gilmartin, Juhee Lee, Lindsay Romo, Stephanie Sacharow
Pages 147-161
Genetics of Phenylalanine Hydroxylase Deficiency
Nenad Blau, Nastassja Himmelreich, Uta Lichter-Konecki
Pages 163-173
PAH Variants Pathogenicity Classification
Diane Zastrow, Uta Lichter-Konecki, William J. Craigen
Pages 175-182
Genetics of BH4 Deficiencies Incl. DNAJC12 Defects
Nastassja Himmelreich, Nenad Blau
Pages 183-196
Management of PKU
Front Matter
Pages 197-197
Download chapter PDF
PKU and Nutrition: Core Concepts and Evolving Care
Anita MacDonald
Pages 199-216
Management of PKU
Pharmacological Therapies
Amaya Bélanger-Quintana, Sinziana Stanescu, Jaume Campistol, Francjan van Spronsen
Pages 217-228
Enzyme Substitution Therapy in Phenylketonuria
Nicola Longo
Pages 229-243
LNAA Therapy
Kirsten Kiær Ahring, Metabolic Dietitian
Pages 245-256
Gene Therapy Approaches for the Treatment of Phenylketonuria
Michael A. Martinez, Laura J. Young, Cary O. Harding, Gerald Schwank, Beat Thöny
Pages 257-283
Discerning the Future of Therapy for PKU
Jerry Vockley
Pages 285-293
Maternal PKU
Maria Giżewska, Alicja Leśniak
Pages 295-313
Follow-Up of PKU Patients
F. Feillet, E. Feigerlova, M. Canton, R. Falda, E. Jeannesson, A. Wiedemann
Pages 315-329
Lost to Follow-Up: The Challenges of Maintaining Contact Through the Lifespan
Sandra Sirrs, Anna Lehman, Graeme A. M. Nimmo
Pages 331-350
Neurocognitive Outcome and Assessment
Cristina Romani
Pages 351-372
The Gut Microbiome and PKU
Elvira Verduci, Martina Tosi, Elisa Borghi
Pages 373-389
Comorbidities in Adults with PKU
François Maillot, Alvaro Hermida, Ida Vanessa Doederlein Schwartz
Pages 391-401
Late-Diagnosed and Untreated Phenylketonuria
Yılmaz Yıldız, Serap Sivri
Pages 403-419
Women’s Health in PKU
Gisela Wilcox
Pages 421-446
Maternal BH4 Deficiency
Maria Giżewska, Daria Katuszonek
Pages 447-459
The “Real Story” of Treated PKU Patients
Elaina Jurecki
Pages 461-477
Guidelines and Resources
Front Matter
Pages 479-479
Download chapter PDF
European Guidelines on Diagnosis and Treatment of Phenylketonuria: First Revision
Annemiek M. J. van Wegberg, Anita MacDonald, Francjan van Spronsen
Pages 481-492
International Guideline for Tetrahydrobiopterin (BH4) Deficiencies
Oya Kuseyri Hübschmann
Pages 493-496
The International Working Group on Neurotransmitter-Related Disorders (iNTD)
Katrin Jeltsch, Thomas Opladen
Pages 497-501
Back Matter
Pages 503-534
Στείλτε μια ερώτηση για το προϊόν
Von Hippel-Lindau Disease. A Comprehensive Guide to Diagnosis, Treatment, and Management
40,00€ 46,00€
23-28 ημέρες
Nutrition Management of Inherited Metabolic Diseases. Lessons from Metabolic University
